Miniaturized HIA microdiagonal pump as left ventricular assist device in a sheep model.

Area of Science:

• Biomedical Engineering
• Cardiovascular Devices
• Surgical Technology

Background:

• Left ventricular assist devices (LVADs) are crucial for managing heart failure.
• Existing LVADs face challenges related to size, durability, and biocompatibility.
• Novel LVAD designs are needed to improve patient outcomes and long-term support.

Purpose of the Study:

• To evaluate the performance and biocompatibility of a newly developed miniaturized HIA microdiagonal blood pump (MDP) as a continuous flow LVAD.
• To assess the feasibility of the MDP in a preclinical animal model.
• To determine the MDP's potential for long-term cardiac support.

Main Methods:

• The miniaturized HIA microdiagonal blood pump (MDP) was implanted in a sheep model (n=6) as a paracorporeal LVAD.
• The device operated continuously at a mean flow rate of 2.5 L/min for 7 days.
• Hemolysis, renal and liver function, and systemic pressures were monitored daily; macroscopic examination was performed post-explantation.

Main Results:

• Systemic arterial pressures remained stable throughout the 7-day study period.
• The MDP demonstrated no significant hemolysis, as indicated by plasma-free hemoglobin levels.
• Temporary, mild impairments in renal and liver function were observed perioperatively but resolved within the study period.

Conclusions:

• The miniaturized HIA microdiagonal blood pump (MDP) successfully functioned as a continuous flow LVAD in a sheep model for 7 days.
• The device exhibited good biocompatibility with no significant hemolysis or wound infections.
• The MDP shows promise as a potential alternative to current LVAD technologies, warranting further investigation in longer-duration studies.